本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Purple Biotech Ltd.

2.30
+0.03001.32%
盘后2.340.0400+1.74%16:33 EDT
成交量:2.66万
成交额:6.12万
市值:624.19万
市盈率:-0.52
高:2.34
开:2.26
低:2.24
收:2.27
数据加载中...
2021/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/23

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/07/17

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/31

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/23

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/11

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/03/10

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/03/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals